Sigma Planning Corp raised its position in shares of Omega Healthcare Investors Inc (NYSE:OHI) by 14.4% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 91,717 shares of the real estate investment trust’s stock after purchasing an additional 11,550 shares during the period. Sigma Planning Corp’s holdings in Omega Healthcare Investors were worth $3,499,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the business. JOYN Advisors Inc. raised its position in shares of Omega Healthcare Investors by 58.4% during the 4th quarter. JOYN Advisors Inc. now owns 1,033 shares of the real estate investment trust’s stock worth $36,000 after buying an additional 381 shares in the last quarter. Massey Quick Simon & CO. LLC purchased a new position in Omega Healthcare Investors during the first quarter valued at approximately $38,000. Spirit of America Management Corp NY purchased a new position in Omega Healthcare Investors during the first quarter valued at approximately $38,000. Reilly Financial Advisors LLC grew its position in Omega Healthcare Investors by 68.1% during the first quarter. Reilly Financial Advisors LLC now owns 992 shares of the real estate investment trust’s stock valued at $38,000 after purchasing an additional 402 shares in the last quarter. Finally, Washington Trust Bank grew its position in Omega Healthcare Investors by 684.9% during the first quarter. Washington Trust Bank now owns 1,146 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 1,000 shares in the last quarter. 69.32% of the stock is owned by hedge funds and other institutional investors.
Shares of Omega Healthcare Investors stock traded down $0.63 on Wednesday, reaching $35.19. The stock had a trading volume of 1,325,519 shares, compared to its average volume of 1,656,689. The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 1.16. Omega Healthcare Investors Inc has a fifty-two week low of $28.65 and a fifty-two week high of $40.30. The stock has a market capitalization of $7.53 billion, a price-to-earnings ratio of 11.58, a PEG ratio of 4.78 and a beta of 0.46.
Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Tuesday, May 7th. The real estate investment trust reported $0.34 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.71 by ($0.37). Omega Healthcare Investors had a net margin of 30.17% and a return on equity of 7.02%. The company had revenue of $188.20 million for the quarter, compared to analyst estimates of $190.54 million. During the same quarter in the previous year, the company earned $0.78 earnings per share. Omega Healthcare Investors’s revenue for the quarter was down 2.9% compared to the same quarter last year. As a group, research analysts predict that Omega Healthcare Investors Inc will post 2.99 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Tuesday, April 30th were issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 7.50%. The ex-dividend date was Monday, April 29th. Omega Healthcare Investors’s payout ratio is 86.84%.
In other Omega Healthcare Investors news, Director Ben W. Perks sold 3,000 shares of the stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $37.64, for a total transaction of $112,920.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Robert O. Stephenson sold 10,000 shares of the stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $37.00, for a total transaction of $370,000.00. Following the sale, the chief financial officer now directly owns 233,326 shares in the company, valued at approximately $8,633,062. The disclosure for this sale can be found here. In the last ninety days, insiders sold 75,788 shares of company stock worth $2,810,176. 1.65% of the stock is owned by insiders.
A number of brokerages recently commented on OHI. Zacks Investment Research raised shares of Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research report on Wednesday, May 8th. ValuEngine downgraded shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, April 3rd. Scotiabank assumed coverage on shares of Omega Healthcare Investors in a research report on Thursday, February 7th. They issued a “sector perform” rating and a $39.37 target price for the company. Finally, Stifel Nicolaus downgraded shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $39.00 target price for the company. in a research report on Thursday, February 7th. Seven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $37.05.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Read More: Recession
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.